Arcutis Biotherapeutics, Inc.

ARQTNasdaq· Pharmaceutical Preparations

Price History

Revenue

$376.1M

▲ 91.3% YoY

Net Income

-$16.1M

▲ 88.5% YoY

EPS

$-0.13

▲ 88.8% YoY

Cash

$42.9M

▼ 39.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.